Navigation Links
Bioabsorbable Stents - Global Strategic Business Report - 2013 Profiles 16 Companies inside the Market
Date:6/7/2013

DUBLIN, June 7, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/j6pgb5/bioabsorbable) has announced the addition of the "Bioabsorbable Stents - Global Strategic Business Report" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


This report analyzes the worldwide markets for Bioabsorbable Stents in Thousand Units. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2018. The report profiles 16 companies including many key and niche players such as Abbott Laboratories, Amaranth Medical, Inc., Arterial Remodeling Technologies SA, BIOTRONIK SE & Co. KG, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., and REVA Medical, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. Executive Summary

1. INDUSTRY OVERVIEW

2. PRODUCT OVERVIEW

3. PRODUCT LAUNCH/INTRODUCTION
4. RECENT INDUSTRY ACTIVITY

5. FOCUS ON SELECT GLOBAL PLAYERS

6. GLOBAL MARKET PERSPECTIVE

III. MARKET

1. THE UNITED STATES

2. EUROPE
3. ASIA-PACIFIC
4. REST OF WORLD

IV. COMPETITIVE LANDSCAPE


Companies Mentioned

- 3D Biotek LLC (USA)
- Abbott Laboratories (USA)
- Abbott Vascular (USA)
- Amaranth Medical, Inc. (USA)
- Arterial Remodeling Technologies SA (France)
- Arterius Ltd. (UK)
- Biotronik SE & Co., KG (Germany)
- Elixir Medical Corporation (USA)
- Kyoto Medical Planning Co., Ltd. (Japan)
- OrbusNeich (Hong Kong)
- REVA Medical, Inc. (USA)
- S3V Vascular Technologies Pvt., Ltd. (India)
- Sahajanand Medical Technologies Pvt., Ltd. (India)
- Stron Medical (Germany)
- Tepha, Inc. (USA)
- Xenogenics Corporation (USA)
- Zorion Medical (USA)


For more information visit http://www.researchandmarkets.com/research/j6pgb5/bioabsorbable

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Sector: Cardiovascular Devices


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. OrbusNeich Launches Worlds First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
2. Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, S
3. Global Vascular Stents Market 2012-2016
4. Drug-coated stents prevent leg amputation
5. Largest Prospective Study Shows IVUS-Guided Stent Placement Improves Patient Outcomes with Current Generation of Stents
6. U.S. Physician Survey: Stents by Brand, Length, Diameter, Type and Coating 2012
7. Global Drug-Eluting Stents Industry
8. Lexicon To Present At The Goldman Sachs Global Healthcare Conference
9. BD to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
10. Quest Diagnostics CEO Steve Rusckowski Reaffirms Full-Year 2013 Guidance At The Jefferies 2013 Global Healthcare Conference
11. Frost & Sullivan: Standardized Regulations Crucial for Growth in Global Dimensional Metrology Market for Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
(Date:5/24/2016)... May 24, 2016 The ... world , s first dual therapy stent, ...   OrbusNeich, a global company specializing in ... portfolio to include products to treat peripheral artery disease. ... first entry devices for lower limb and arteriovenous (AV) ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse à ... destinés à l,intervention portant sur les membres ... OrbusNeich, entreprise mondiale spécialisée dans ... changer la vie, a élargi son portefeuille ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... ... of thousands of defective respirators, according to court documents and SEC filings. ... William and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through its ... partner for the Tamika Catchings Legacy Tour that will commemorate the Indiana ... hardwood basketball surfaces in all forms and levels of the game, Connor Sports has ...
(Date:5/26/2016)... Pittsburgh, PA (PRWEB) , ... May 26, 2016 ... ... transplantation, and one that has a significant negative impact on long-term patient survival, ... to date. The results, published online this week in the Journal of Thoracic ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, ... biologics, consumer health and global clinical supply services, today announced two key appointments ... company’s continued investment and strategic growth plans in the Asia Pacific region. , ...
(Date:5/26/2016)... ... ... effort to provide hair restoration information to the widest possible audience, Dr. Parsa Mohebi is ... the app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, is making all of ... Mohebi says, “The positive response to the Snapchat videos we started last month has been ...
Breaking Medicine News(10 mins):